KPTI Karyopharm Therapeutics Inc. - Common Stock
$1,99
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 13, 2026
Zakres 52 tyg.
$2–$11
2% of range
Ocena Analityków
BUY
12 analysts
Cena Docelowa
$7
+264% upside
P/E (TTM)
-0.1
ROE
73.7%
Marża Zysku Netto
-134.2%
KPTI Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$1.99
Kapitalizacja Rynkowa
$36M
P/E (TTM)
-0.1
EPS (TTM)
$-17.93
Przychody (TTM)
$146M
Stopa dywidendy
—
ROE
73.7%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $11
KPTI Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$146M
2016-12-31
→
2025-12-31
EPS
$-17.93
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-75M
2016-12-31
→
2025-12-31
Marże
-134.2%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
KPTI
Mediana porównawcza
P/E (TTM)
-0.1
0.8
P/S (TTM)
0.2
6.2
P/B
-0.1
3.0
Price / FCF (Cena / FCF)
-0.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
KPTI
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-62.1%
—
Net Profit Margin (Marża Zysku Netto)
-134.2%
-1056.6%
ROA
-143.7%
-118.6%
ROE
73.7%
-139.5%
ROIC
31.0%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
KPTI
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
1.1
2.1
Quick Ratio (Wskaźnik Szybkości)
0.9
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
KPTI
Mediana porównawcza
Revenue YoY (Przychody R/R)
0.57%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-2.4%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
6.2%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
KPTI
Mediana porównawcza
KPTI Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
12 analityków
- Mocne kupno 3 25,0%
- Kup 6 50,0%
- Trzymaj 3 25,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
4 analityków · 2026-08-19
Mediana
$7.50
← Poniżej wszystkich celów
$1.99
Niski
$3.00
Wysoki
$11.00
Średni cel
$7.50
+276,7%
Średnia cel
$7.25
+264,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-2.32 | $-1.30 | -1.0% |
| 31 marca 2026 | $-1.02 | $-1.46 | 0.44% |
| 31 grudnia 2025 | $-2.22 | $-2.03 | -0.19% |
| 30 września 2025 | $-3.82 | $-3.19 | -0.63% |
| 30 czerwca 2025 | $-4.32 | $-4.18 | -0.14% |
| 31 marca 2025 | $-2.77 | $-4.26 | 1.5% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | — |
| TIL | $75M | -1.0 | — | — | -58.1% | — |
| MGX | $61M | -0.7 | -51.8% | -348.5% | -49.6% | — |
| MCRB | $142M | 23.2 | — | 721.9% | 14.8% | — |
| ALGS | $58M | -3.8 | -39.5% | -1106.7% | -31.1% | — |
| CRVO | $73M | — | -58.9% | -673.1% | -104.4% | — |
| TVGN | — | — | — | — | — | — |
| ELUT | — | 0.8 | -15.0% | 434.2% | -753.4% | 53.7% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $146M | $145M | $146M | $157M | $210M | $108M | $41M | $30M | $2M | $154.0K | $250.0K | $229.0K | |
| R&D Expense | $126M | $143M | $139M | $149M | $161M | $151M | $122M | $161M | $107M | $87M | $98M | $60M | |
| SG&A Expense | $105M | $115M | $132M | $145M | $144M | $126M | $105M | $49M | $25M | $24M | $22M | $16M | |
| Operating Expenses | $237M | $265M | $276M | $299M | $308M | $280M | $230M | $210M | $132M | $111M | $119M | $76M | |
| Operating Income | $-91M | $-119M | $-130M | $-142M | $-98M | $-172M | $-189M | $-180M | $-131M | $-111M | $-119M | $-76M | |
| Interest Expense | · | · | $24M | $25M | $26M | $27M | $16M | $2M | · | · | · | $1.0K | |
| Interest Income | $3M | $7M | $11M | $2M | $582.0K | $3M | $5M | $4M | $2M | $1M | $897.0K | $97.0K | |
| Other Non-op | $152.0K | $28M | $-356.0K | $-83.0K | $-85.0K | $206.0K | $-50.0K | $-33.0K | $-81.0K | $10.0K | $-2.0K | $-27.0K | |
| Pretax Income | $-196M | $-76M | $-143M | $-165M | $-124M | $-196M | $-200M | $-178M | $-129M | $-109M | $-118M | $-76M | |
| Income Tax | $43.0K | $57.0K | $323.0K | $369.0K | $268.0K | $309.0K | $40.0K | $26.0K | $63.0K | $139.0K | $-118M | $-76M | |
| Net Income | $-196M | $-76M | $-143M | $-165M | $-124M | $-196M | $-200M | $-178M | $-129M | $-110M | $-118M | $-76M | |
| EPS (Basic) | $-17.93 | $-9.41 | $-18.79 | $-2.02 | $-1.65 | $-2.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-17.93 | $-14.00 | $-18.79 | $-2.02 | $-1.65 | $-2.72 | · | · | · | · | · | · | |
| Shares (Basic) | 10,935 | 8,125 | 7,616 | 81,871 | 75,218,000 | 72,044,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 10,935 | 8,455 | 7,616 | 81,871 | 75,218,000 | 72,044,000 | · | · | · | · | · | · | |
| EBITDA | $-91M | $-119M | $-130M | $-142M | $-98M | $-172M | $-189M | $-180M | $-131M | $-111M | $-119M | $-76M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $62M | $52M | $135M | $190M | $86M | $129M | $118M | $69M | $50M | $58M | $151M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $77M | $80M | $117M | $55M | |
| Receivables | $26M | $31M | $27M | $47M | $22M | $13M | $8M | · | · | · | · | · | |
| Inventory | $4M | $5M | $3M | $4M | $4M | $3M | $346.0K | · | · | · | · | · | |
| Prepaid Expense | $9M | $12M | $12M | $20M | $14M | $9M | $7M | $6M | $2M | $2M | $2M | $2M | |
| Other Current Assets | · | · | · | · | $2M | · | · | · | · | · | · | · | |
| Current Assets | $103M | $156M | $234M | $350M | $276M | $277M | $279M | $335M | $148M | $132M | $178M | $208M | |
| PP&E (Net) | $104.0K | $400.0K | $606.0K | $1M | $2M | $2M | $3M | $4M | $2M | $3M | $3M | $3M | |
| PP&E (Gross) | $6M | $7M | $7M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $5M | $3M | |
| Accum. Depreciation | $6M | $7M | $7M | $7M | $6M | $5M | $4M | $3M | $3M | $2M | $1M | $494.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $774.0K | |
| Total Assets | $108M | $164M | $240M | $358M | $305M | $313M | $295M | $341M | $180M | $180M | $215M | $220M | |
| Accounts Payable | $4M | $5M | $3M | $3M | $2M | $4M | $985.0K | $4M | $6M | $5M | $4M | $6M | |
| Accrued Liabilities | $64M | $61M | $61M | $58M | $69M | $53M | $41M | $32M | $21M | $11M | $11M | $6M | |
| Current Liabilities | $92M | $92M | $69M | $66M | $74M | $60M | $46M | $47M | $49M | $16M | $15M | $12M | |
| Capital Leases | $6M | $7M | $3M | $6M | $9M | $11M | $13M | · | · | · | · | · | |
| Other Non-current Liabilities | $11M | $2M | $978.0K | $0 | · | · | · | · | · | · | · | · | |
| Total Liabilities | $401M | $350M | $377M | $375M | $385M | $263M | $245M | $158M | $51M | $18M | $17M | $14M | |
| Long-term Debt | · | · | · | · | $169M | · | · | · | · | · | · | · | |
| Common Stock | $14.0K | $13.0K | $12.0K | $12.0K | $8.0K | $7.0K | $7.0K | $6.0K | $5.0K | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $345M | |
| Retained Earnings | $-1.76B | $-1.56B | $-1.49B | $-1.34B | $-1.18B | $-1.07B | $-873M | $-674M | $-495M | $-366M | $-257M | $-138M | |
| AOCI | $71.0K | $-356.0K | $-161.0K | $-638.0K | $191.0K | $518.0K | $-37.0K | $-244.0K | $-217.0K | $-274.0K | $-282.0K | $-29.0K | |
| Stockholders' Equity | $-293M | $-186M | $-136M | $-17M | $-80M | $51M | $50M | $183M | $129M | $162M | $198M | $207M | |
| Liabilities + Equity | $108M | $164M | $240M | $358M | $305M | $313M | $295M | $341M | $180M | $180M | $215M | $220M | |
| Shares Outstanding | 18,311,000 | 8,413,000 | 114,915,000 | 113,213,000 | 75,746,000 | 73,923,000 | 65,370,000 | 60,829,308 | 49,533,150 | 41,887,829 | 35,864,765 | 32,699,380 |
Przepływy pieniężne 12
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $974.0K | $735.0K | $713.0K | $717.0K | $634.0K | $323.0K | |
| Stock-based Comp | $14M | $18M | $22M | $35M | $30M | $24M | $15M | $17M | $20M | $22M | $17M | $14M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | |
| Operating Cash Flow | $-75M | $-127M | $-93M | $-150M | $-107M | $-160M | $-191M | $-159M | $-74M | $-84M | $-94M | $-51M | |
| CapEx | $0 | $142.0K | $0 | $118.0K | $212.0K | $145.0K | $206.0K | $2M | $62.0K | $70.0K | $1M | $3M | |
| Investing Cash Flow | $43M | $95M | $8M | $-104M | $142M | $-54M | $78M | $-108M | $17M | $25M | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $113M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | $113M | |
| Financing Cash Flow | $30M | $42M | $1M | $194M | $74M | $172M | $124M | $316M | $76M | $51M | · | · | |
| Net Change in Cash | $-2M | $10M | $-84M | $-61M | $108M | $-42M | $12M | $49M | $19M | $-9M | $-92M | $-5M | |
| Free Cash Flow | $-75M | $-128M | $-93M | $-150M | $-107M | $-160M | $-191M | $-161M | $-74M | $-84M | $-95M | $-54M | |
| Levered FCF | · | · | $-117M | $-175M | $-133M | $-188M | $-207M | $-164M | · | · | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% | -159.0% | -462.8% | -593.0% | · | -71903.9% | -47630.4% | -33120.5% | |
| Net Margin | -134.2% | -52.6% | -98.0% | -105.2% | -59.1% | -181.6% | -488.1% | -588.1% | · | -71153.9% | -47272.4% | -33090.4% | |
| Pretax Margin | -134.2% | -52.6% | -97.8% | -105.0% | -59.0% | -181.3% | -488.0% | -588.0% | · | -71063.6% | · | · | |
| EBITDA Margin | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% | -159.0% | -462.8% | -593.0% | · | -71903.9% | -47630.4% | -33120.5% | |
| ROA | -143.7% | -37.8% | -47.8% | -49.8% | -40.1% | -64.6% | -62.7% | -68.4% | -71.5% | -55.4% | -54.2% | -40.0% | |
| ROE | 73.7% | 44.2% | 121.0% | 210.7% | 120.7% | -292.3% | -364.1% | -100.7% | -88.4% | -60.8% | -58.3% | -41.9% | |
| ROIC | 31.0% | 64.3% | 95.3% | 855.7% | 123.6% | -340.5% | -380.4% | -98.2% | -100.9% | -68.3% | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 1.7 | 3.4 | 5.3 | 3.7 | 4.6 | 6.0 | 7.1 | 3.0 | 8.0 | 11.7 | 16.9 | |
| Quick Ratio | 0.9 | 1.0 | 1.1 | 2.8 | 2.9 | 1.6 | 2.9 | 2.5 | 3.0 | 7.9 | 11.6 | 16.7 | |
| Interest Coverage | · | · | -5.4 | -5.7 | -3.8 | -6.3 | -12.1 | -72.2 | · | · | · | -75846.0 |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 0.7 | 0.5 | 0.5 | 0.7 | 0.4 | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 5.1 | 5.0 | 3.9 | 4.5 | 11.9 | 10.4 | 10.4 | · | · | · | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.57% | -0.55% | -7.0% | -25.1% | 94.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -2.4% | -11.5% | 10.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.2% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $146M | $145M | $146M | $157M | $210M | $108M | $41M | $30M | $2M | $154.0K | $250.0K | $229.0K | |
| Net Income TTM | $-196M | $-76M | $-143M | $-165M | $-124M | $-196M | $-200M | $-178M | $-129M | $-110M | $-118M | $-76M | |
| Market Cap | $135M | $1.28B | $1.49B | $5.77B | $7.31B | $17.16B | $18.80B | $8.55B | $7.13B | $5.91B | $7.13B | $18.36B | |
| P/E | -0.4 | -0.7 | -0.7 | -25.2 | -58.5 | -85.4 | · | · | · | · | · | · | |
| P/S | 0.9 | 8.8 | 10.2 | 36.8 | 34.8 | 158.8 | 459.7 | 281.8 | 4444.1 | 38351.8 | 28512.5 | 80170.6 | |
| P/B | -0.5 | -6.9 | -10.9 | -346.7 | -91.7 | 339.6 | 377.7 | 46.7 | 55.1 | 36.4 | 35.9 | 88.8 | |
| P / Tangible Book | · | · | · | · | · | 339.6 | · | · | · | · | · | · | |
| P / Cash Flow | -1.8 | -10.0 | -16.1 | -38.6 | -68.2 | -107.1 | -98.5 | -53.7 | -96.8 | -70.0 | -75.8 | -356.9 | |
| P / FCF | -1.8 | -10.0 | -16.1 | -38.6 | -68.1 | -107.0 | -98.4 | -52.9 | -96.7 | -69.9 | -74.7 | -338.2 | |
| Earnings Yield | -243.6% | -138.1% | -144.8% | -4.0% | -1.7% | -1.2% | · | · | · | · | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $33M | $35M | $34M | $44M | $38M | $30M | $31M | $39M | $43M | $33M | $34M | $36M | $38M | $39M | $34M | $36M | |
| R&D Expense | $29M | $34M | $28M | $31M | $33M | $35M | $33M | $36M | $38M | $35M | $39M | $36M | $31M | $32M | $31M | $31M | |
| SG&A Expense | $26M | $27M | $23M | $27M | $28M | $27M | $27M | $28M | $31M | $30M | $31M | $31M | $34M | $36M | $35M | $35M | |
| Operating Expenses | $56M | $62M | $52M | $59M | $62M | $63M | $62M | $65M | $71M | $67M | $72M | $67M | $67M | $70M | $67M | $67M | |
| Operating Income | $-23M | $-27M | $-18M | $-15M | $-24M | $-33M | $-31M | $-26M | $-28M | $-34M | $-38M | $-31M | $-30M | $-31M | $-34M | $-31M | |
| Interest Expense | · | · | · | · | · | · | · | · | $9M | $6M | · | $6M | $6M | $6M | · | $6M | |
| Interest Income | $722.0K | $511.0K | $607.0K | $553.0K | $613.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $1M | $658.0K | |
| Other Non-op | $-32M | $16M | $-10M | $-7M | $-2M | $20M | $10M | $4M | $14M | $196.0K | $-211.0K | $89.0K | $30.0K | $-264.0K | $-13.0K | $16.0K | |
| Pretax Income | $-67M | $-22M | $-102M | $-33M | $-37M | $-23M | $-31M | $-32M | $24M | $-37M | $-42M | $-34M | $-33M | $-34M | $-38M | $-36M | |
| Income Tax | $0 | $1.0K | $-67.0K | $34.0K | $40.0K | $36.0K | $-109.0K | $28.0K | $67.0K | $71.0K | $130.0K | $12.0K | $127.0K | $54.0K | $73.0K | $45.0K | |
| Net Income | $-67M | $-22M | $-102M | $-33M | $-37M | $-23M | $-31M | $-32M | $24M | $-37M | $-42M | $-35M | $-33M | $-34M | $-39M | $-36M | |
| EPS (Basic) | $-2.32 | $-1.02 | $-7.02 | $-3.82 | $-4.32 | $-2.77 | $-2.97 | $-3.85 | $2.26 | $-4.85 | $-17.90 | $-0.30 | $-0.29 | $-0.30 | $-0.42 | $-0.45 | |
| EPS (Diluted) | $-2.32 | $-1.24 | $-7.02 | $-3.82 | $-4.32 | $-2.77 | $-2.33 | $-3.85 | $-2.97 | $-4.85 | $-17.90 | $-0.30 | $-0.29 | $-0.30 | $-0.42 | $-0.45 | |
| Shares (Basic) | 28,938 | 22,014 | -14,824 | 8,669 | 8,620 | 8,470 | -15,980 | 8,336 | 8,069 | 7,700 | -227,794,785 | 114,401 | 114,207,000 | 113,481,000 | -237,349,129 | 80,210,000 | |
| Shares (Diluted) | 28,938 | 24,715 | -14,824 | 8,669 | 8,620 | 8,470 | -17,876 | 8,336 | 10,295 | 7,700 | -227,794,785 | 114,401 | 114,207,000 | 113,481,000 | -237,349,129 | 80,210,000 | |
| EBITDA | · | $-27M | · | $-15M | $-24M | $-33M | · | $-26M | $-28M | $-34M | · | $-31M | $-30M | $-31M | · | $-31M |
Bilans 22
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $55M | $91M | $61M | $38M | $39M | $39M | $62M | $73M | $85M | $31M | $52M | $44M | $81M | $84M | $135M | $71M | |
| Receivables | $30M | $23M | $26M | $32M | $33M | $35M | $31M | $32M | $38M | $31M | · | $38M | $32M | $35M | · | $27M | |
| Inventory | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $3M | $3M | · | $3M | $4M | $4M | · | $4M | |
| Prepaid Expense | $7M | $9M | $9M | $8M | $8M | $10M | $12M | $15M | $15M | $15M | · | $13M | $18M | $18M | · | $10M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $31M | |
| Current Assets | $106M | $126M | $103M | $90M | $98M | $120M | $156M | $185M | $209M | $198M | · | $263M | $291M | $319M | · | $223M | |
| PP&E (Net) | $94.0K | $91.0K | $104.0K | $122.0K | $244.0K | $322.0K | $400.0K | $495.0K | $628.0K | $719.0K | · | $686.0K | $766.0K | $849.0K | · | $1M | |
| PP&E (Gross) | · | · | $6M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $6M | · | · | · | $7M | · | · | · | · | · | · | · | · | · | |
| Total Assets | $111M | $131M | $108M | $96M | $105M | $128M | $164M | $189M | $214M | $204M | · | $270M | $298M | $326M | · | $231M | |
| Accounts Payable | $8M | $4M | $4M | $5M | $3M | $6M | $5M | $6M | $3M | $5M | · | $943.0K | $2M | $9M | · | $813.0K | |
| Accrued Liabilities | $79M | $76M | $64M | $66M | $63M | $57M | $61M | $50M | $50M | $55M | · | $56M | $52M | $47M | · | $56M | |
| Current Liabilities | $134M | $117M | $92M | $87M | $99M | $90M | $92M | $61M | $58M | $65M | · | $62M | $59M | $62M | · | $62M | |
| Capital Leases | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $0 | $955.0K | $2M | · | $4M | $4M | $5M | · | $7M | |
| Other Non-current Liabilities | $336.0K | $278.0K | $11M | $14M | $8M | $5M | $2M | $6M | $4M | $3M | · | $1M | $2M | $1M | · | · | |
| Total Liabilities | $441M | $397M | $401M | $365M | $344M | $334M | $350M | $349M | $346M | $373M | · | $370M | $369M | $371M | · | $372M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $13.0K | $12.0K | · | $12.0K | $12.0K | $12.0K | · | $8.0K | |
| Retained Earnings | $-1.85B | $-1.78B | $-1.76B | $-1.66B | $-1.62B | $-1.59B | $-1.56B | $-1.53B | $-1.50B | $-1.52B | · | $-1.45B | $-1.41B | $-1.38B | · | $-1.31B | |
| AOCI | $41.0K | $43.0K | $71.0K | $-259.0K | $-251.0K | $-321.0K | $-356.0K | $-222.0K | $-605.0K | $-518.0K | · | $-742.0K | $-783.0K | $-419.0K | · | $-752.0K | |
| Stockholders' Equity | $-330M | $-266M | $-293M | $-269M | $-239M | $-206M | $-186M | $-160M | $-132M | $-169M | $-136M | $-100M | $-71M | $-45M | $-17M | $-140M | |
| Liabilities + Equity | $111M | $131M | $108M | $96M | $105M | $128M | $164M | $189M | $214M | $204M | · | $270M | $298M | $326M | · | $231M | |
| Shares Outstanding | 22,680,000 | 22,544,000 | 18,311,000 | 8,702,000 | 8,647,000 | 8,568,000 | 8,413,000 | 125,303,000 | 124,635,000 | 116,457,000 | · | 114,523,000 | 114,340,000 | 113,971,000 | · | 81,027,000 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $3M | $4M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $5M | $6M | $7M | |
| Operating Cash Flow | $-25M | $-23M | $-12M | $-6M | $-19M | $-39M | $-26M | $-19M | $-38M | $-44M | $-19M | $-30M | $-26M | $-19M | $-27M | $-28M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $-53.0K | $0 | $0 | $195.0K | $0 | $0 | $0 | $0 | $0 | $39.0K | |
| Investing Cash Flow | $-10M | $3M | $5M | $5M | $18M | $15M | $15M | $7M | $51M | $22M | $27M | $-8M | $21M | $-32M | $-65M | $12M | |
| Stock Issued | $0 | $20M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $20M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-898.0K | $50M | $30M | $0 | $356.0K | $0 | $680.0K | $0 | · | · | $264.0K | $0 | $860.0K | $0 | $156M | $6M | |
| Net Change in Cash | $-36M | $30M | $23M | $-1M | $-48.0K | $-24M | $-10M | $-12M | $54M | $-22M | $9M | $-37M | $-4M | $-51M | $64M | $-11M | |
| Free Cash Flow | · | · | · | · | · | $-39M | · | · | · | $-44M | · | · | · | $-19M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-50M | · | · | · | $-25M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -76.3% | · | -34.6% | -64.3% | -110.8% | · | -67.8% | -65.7% | -101.9% | · | -86.8% | -78.7% | -79.8% | · | -85.3% | |
| Net Margin | · | -63.9% | · | -75.2% | -98.2% | -78.2% | · | -82.7% | 55.6% | -112.8% | · | -95.8% | -86.8% | -88.2% | · | -100.5% | |
| Pretax Margin | · | -63.8% | · | -75.1% | -98.1% | -78.0% | · | -82.6% | 55.8% | -112.6% | · | -95.8% | -86.5% | -88.0% | · | -100.4% | |
| EBITDA Margin | · | -76.3% | · | -34.6% | -64.3% | -110.8% | · | -67.8% | -65.7% | -101.9% | · | -86.8% | -78.7% | -79.8% | · | -85.3% | |
| ROA | · | -17.3% | · | -23.2% | -23.4% | -14.1% | · | -14.0% | 9.3% | -14.1% | · | -13.8% | -11.8% | -11.0% | · | -15.0% | |
| ROE | · | 9.5% | · | 15.4% | 20.1% | 12.5% | · | 24.7% | -23.4% | 34.9% | · | 28.7% | 34.8% | 53.2% | · | 27.3% | |
| ROIC | · | 10.1% | · | 5.7% | 10.2% | 16.2% | · | 16.5% | 21.2% | 20.0% | · | 31.1% | 41.7% | 68.5% | · | 22.0% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.1 | · | 1.0 | 1.0 | 1.3 | · | 3.0 | 3.6 | 3.0 | · | 4.2 | 4.9 | 5.2 | · | 3.6 | |
| Quick Ratio | · | 1.0 | · | 0.8 | 0.7 | 0.8 | · | 1.7 | 2.1 | 0.9 | · | 1.3 | 1.9 | 1.9 | · | 1.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -3.1 | -5.7 | · | -5.1 | -5.1 | -5.4 | · | -5.0 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | · | 1.2 | · | 1.4 | 1.1 | 0.9 | · | 1.1 | 1.2 | 1.0 | · | 1.1 | 1.3 | 1.3 | · | 1.6 |
Wycena (TTM) 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $147M | $147M | · | $151M | $150M | $145M | · | $151M | $150M | $145M | · | $148M | $152M | $162M | · | $161M | |
| Net Income TTM | $-116M | $-116M | · | $-126M | $-69M | $-69M | · | $-80M | $-81M | $-139M | · | $-138M | $-152M | $-161M | · | $-179M | |
| Market Cap | · | $126M | · | $57M | $37M | $32M | · | $1.56B | $1.62B | $2.64B | · | $2.30B | $3.07B | $6.65B | · | $6.64B | |
| P/E | -0.8 | -0.5 | · | -0.4 | -0.3 | -0.3 | · | -1.0 | -1.5 | -3.9 | · | -15.0 | -16.2 | -30.7 | · | -35.8 | |
| P/S | · | 0.9 | · | 0.4 | 0.2 | 0.2 | · | 10.4 | 10.9 | 18.1 | · | 15.5 | 20.2 | 41.0 | · | 41.2 | |
| P/B | -0.7 | -0.5 | · | -0.2 | -0.2 | -0.2 | · | -9.8 | -12.3 | -15.6 | · | -22.9 | -43.1 | -147.2 | · | -47.3 | |
| P / Cash Flow | · | -5.5 | · | · | · | -0.8 | · | · | · | -60.3 | · | · | · | -351.7 | · | · | |
| P / FCF | · | · | · | · | · | -0.8 | · | · | · | -60.1 | · | · | · | -351.7 | · | · | |
| Earnings Yield | -124.4% | -218.1% | · | -225.7% | -322.7% | -386.1% | · | -96.1% | -64.6% | -25.3% | · | -6.7% | -6.2% | -3.3% | · | -2.8% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $146M | $145M | $146M | $157M | $210M |
| Marża Operacyjna % | -62.1% | -82.2% | -88.7% | -90.5% | -46.8% |
| Zysk netto | $-196M | $-76M | $-143M | $-165M | $-124M |
| Rozwodniony EPS | $-17.93 | $-14.00 | $-18.79 | $-2.02 | $-1.65 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.1 | 1.7 | 3.4 | 5.3 | 3.7 |
| Wskaźnik Szybkości | 0.9 | 1.0 | 1.1 | 2.8 | 2.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-75M | $-128M | $-93M | $-150M | $-107M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 113 emitentów · $188.5M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 43 (+2 vs poprzedni kw.) | 17 (+4 vs poprzedni kw.) | 29 (-6 vs poprzedni kw.) | 21 (+13 vs poprzedni kw.) | -3.8M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $18 732 549 | 1 917 354 | 9,94% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $14 863 316 | 1 521 322 | 7,89% | Akcje |
| ACORN CAPITAL ADVISORS, LLC | $14 831 964 | 1 518 113 | 7,87% | Akcje |
| GOLDMAN SACHS GROUP INC | $13 567 540 | 1 388 694 | 7,20% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $9 369 225 | 958 979 | 4,97% | Akcje |
| Catalio Capital Management, LP | $9 192 153 | 940 855 | 4,88% | Akcje |
| Avidity Partners Management LP | $9 032 238 | 924 487 | 4,79% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $6 792 729 | 695 264 | 3,60% | Akcje |
| Kalehua Capital Management LLC | $6 698 742 | 685 644 | 3,55% | Akcje |
| NEA Management Company, LLC | $5 635 141 | 576 780 | 2,99% | Akcje |
| Ghisallo Capital Management LLC | $4 885 000 | 500 000 | 2,59% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 736 496 | 484 800 | 2,51% | Opcja kupna |
| GEODE CAPITAL MANAGEMENT, LLC | $4 332 097 | 443 276 | 2,30% | Akcje |
| Soleus Capital Management, L.P. | $4 298 800 | 440 000 | 2,28% | Akcje |
| UBS Group AG | $3 454 096 | 353 541 | 1,83% | Akcje |
| STATE STREET CORP | $3 184 932 | 325 991 | 1,69% | Akcje |
| Affinity Asset Advisors, LLC | $3 053 125 | 312 500 | 1,62% | Akcje |
| Brevan Howard Capital Management LP | $3 026 912 | 309 817 | 1,61% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $2 986 455 | 305 676 | 1,58% | Akcje |
| Boxer Capital Management, LLC | $2 955 777 | 302 536 | 1,57% | Akcje |
| Davidson Kempner Capital Management LP | $2 931 000 | 300 000 | 1,56% | Akcje |
| SILVERARC CAPITAL MANAGEMENT, LLC | $2 906 184 | 297 460 | 1,54% | Akcje |
| Caption Management, LLC | $2 791 289 | 285 700 | 1,48% | Opcja kupna |
| Eversept Partners, LP | $2 698 220 | 276 174 | 1,43% | Akcje |
| Tetragon Partners GP Ltd | $2 445 431 | 250 300 | 1,30% | Opcja kupna |
| Trexquant Investment LP | $1 840 355 | 188 368 | 0,98% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $1 837 131 | 188 038 | 0,97% | Akcje |
| BARCLAYS PLC | $1 601 958 | 163 967 | 0,85% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 420 568 | 145 401 | 0,75% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 317 172 | 134 818 | 0,70% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $1 057 251 | 108 214 | 0,56% | Akcje |
| DLD Asset Management, LP | $989 625 | 101 500 | 0,53% | Opcja sprzedaży |
| SILVERBACK ASSET MANAGEMENT LLC | $977 000 | 100 000 | 0,52% | Opcja kupna |
| Jump Financial, LLC | $918 380 | 94 000 | 0,49% | Akcje |
| Caption Management, LLC | $903 725 | 92 500 | 0,48% | Opcja sprzedaży |
| BlackRock, Inc. | $841 881 | 86 170 | 0,45% | Akcje |
| DLD Asset Management, LP | $780 975 | 80 100 | 0,41% | Opcja kupna |
| Connor, Clark & Lunn Investment Management Ltd. | $746 399 | 76 397 | 0,40% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $702 199 | 71 873 | 0,37% | Akcje |
| J. Goldman & Co LP | $660 452 | 67 600 | 0,35% | Opcja sprzedaży |
| TWO SIGMA ADVISERS, LP | $660 405 | 89 729 | 0,35% | Akcje |
| J. Goldman & Co LP | $659 475 | 67 500 | 0,35% | Akcje |
| Squarepoint Ops LLC | $623 336 | 63 801 | 0,33% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $605 183 | 61 943 | 0,32% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $594 993 | 60 900 | 0,32% | Opcja sprzedaży |
| Susquehanna Portfolio Strategies, LLC | $532 905 | 54 545 | 0,28% | Akcje |
| XTX Topco Ltd | $520 467 | 53 272 | 0,28% | Akcje |
| CITADEL ADVISORS LLC | $509 994 | 52 200 | 0,27% | Opcja kupna |
| CITADEL ADVISORS LLC | $508 714 | 52 069 | 0,27% | Akcje |
| MARSHALL WACE, LLP | $376 487 | 38 535 | 0,20% | Akcje |
| BANK OF AMERICA CORP /DE/ | $369 521 | 37 822 | 0,20% | Akcje |
| CITIGROUP INC | $359 223 | 36 768 | 0,19% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $351 720 | 36 000 | 0,19% | Opcja sprzedaży |
| Engineers Gate Manager LP | $331 848 | 33 966 | 0,18% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $326 000 | 33 333 | 0,17% | Akcje |
| JANE STREET GROUP, LLC | $324 100 | 33 173 | 0,17% | Akcje |
| TORONTO DOMINION BANK | $302 186 | 30 930 | 0,16% | Akcje |
| SILVERBACK ASSET MANAGEMENT LLC | $293 100 | 30 000 | 0,16% | Akcje |
| Baird Financial Group, Inc. | $291 058 | 29 791 | 0,15% | Akcje |
| JANE STREET GROUP, LLC | $286 261 | 29 300 | 0,15% | Opcja kupna |
| ExodusPoint Capital Management, LP | $259 706 | 26 582 | 0,14% | Akcje |
| China Universal Asset Management Co., Ltd. | $244 250 | 25 000 | 0,13% | Akcje |
| SIMPLEX TRADING, LLC | $235 320 | 24 086 | 0,12% | Akcje |
| JANE STREET GROUP, LLC | $232 526 | 23 800 | 0,12% | Opcja sprzedaży |
| RHUMBLINE ADVISERS | $229 266 | 23 467 | 0,12% | Akcje |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $227 299 | 23 265 | 0,12% | Akcje |
| Velan Capital Investment Management LP | $195 400 | 20 000 | 0,10% | Akcje |
| DEUTSCHE BANK AG\ | $189 782 | 19 425 | 0,10% | Akcje |
| WELLS FARGO & COMPANY/MN | $165 142 | 16 903 | 0,09% | Akcje |
| HSBC HOLDINGS PLC | $137 363 | 13 750 | 0,07% | Akcje |
| CITADEL ADVISORS LLC | $133 849 | 13 700 | 0,07% | Opcja sprzedaży |
| Headlands Technologies LLC | $118 344 | 12 113 | 0,06% | Akcje |
| MetLife Investment Management, LLC | $117 406 | 12 017 | 0,06% | Akcje |
| Nuveen, LLC | $109 346 | 11 192 | 0,06% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $101 364 | 10 375 | 0,05% | Akcje |
| Quadrature Capital Ltd | $100 592 | 10 296 | 0,05% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $89 601 | 9 171 | 0,05% | Akcje |
| FMR LLC | $87 305 | 8 936 | 0,05% | Akcje |
| JPMORGAN CHASE & CO | $83 272 | 8 257 | 0,04% | Akcje |
| Bank of New York Mellon Corp | $81 267 | 8 318 | 0,04% | Akcje |
| Vanguard Global Advisers, LLC | $80 182 | 8 207 | 0,04% | Akcje |
| Invesco Ltd. | $77 593 | 7 942 | 0,04% | Akcje |
| VANGUARD GROUP INC | $60 404 | 8 207 | 0,03% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $57 389 | 5 874 | 0,03% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $54 712 | 5 600 | 0,03% | Akcje |
| TD Waterhouse Canada Inc. | $54 502 | 5 707 | 0,03% | Akcje |
| NORTHERN TRUST CORP | $30 443 | 3 116 | 0,02% | Akcje |
| Legal & General Group Plc | $18 905 | 1 935 | 0,01% | Akcje |
| Ameritas Investment Partners, Inc. | $17 664 | 1 808 | 0,01% | Akcje |
| Russell Investments Group, Ltd. | $15 553 | 1 592 | 0,01% | Akcje |
| Tower Research Capital LLC (TRC) | $12 300 | 1 259 | 0,01% | Akcje |
| T. Rowe Price Investment Management, Inc. | $7 683 | 786 309 | 0,00% | Akcje |
| ROYAL BANK OF CANADA | $6 000 | 625 | 0,00% | Akcje |
| Sterling Capital Management LLC | $3 439 | 352 | 0,00% | Akcje |
| OSAIC HOLDINGS, INC. | $3 126 | 320 | 0,00% | Akcje |
| ACADIAN ASSET MANAGEMENT LLC | $2 916 | 298 997 | 0,00% | Akcje |
| HARBOUR INVESTMENTS, INC. | $2 784 | 285 | 0,00% | Akcje |
| MORGAN STANLEY | $2 315 | 237 | 0,00% | Akcje |
| Quent Capital, LLC | $1 622 | 166 | 0,00% | Akcje |
| Integrated Wealth Concepts LLC | $1 316 | 134 | 0,00% | Akcje |
Insiderzy spółki 33 insiderów · 20 dyrektorzy generalni · 10 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Richard A. Paulson | President and CEO | 14 maja 2026 S | 269 747 | 0 | 2 | $-29 011 |
| Lori Macomber | EVP, CFO & Treasurer | 3 lutego 2026 S | 85 105 | 0 | 1 | $-10 244 |
| Michael Mason | EVP, CFO & Treasurer | 4 września 2024 S | 391 054 | 0 | 0 | $0 |
| Michael Falvey | EVP, CFO & Treasurer | 24 stycznia 2018 A | — | 0 | 0 | $0 |
| Justin A Renz | EVP, CFO & Treasurer | 20 stycznia 2017 A | 19 173 | 0 | 0 | $0 |
| Stuart Poulton | EVP, Chief Development Officer | 28 lipca 2026 S | 94 632 | 0 | 4 | $-11 010 |
| Kristin Abate | Chief Accounting Officer | 14 maja 2026 S | 23 801 | 0 | 5 | $-4 864 |
| Sohanya Roshan Cheng | EVP & Chief Commercial Officer | 14 maja 2026 S | 107 940 | 0 | 2 | $-5 168 |
| Michael Mano | EVP, CLO&Secretary | 14 maja 2026 S | 94 398 | 0 | 2 | $-4 032 |
| Reshma Rangwala | EVP & Chief Medical Officer | 14 maja 2026 S | 56 829 | 0 | 2 | $-6 499 |
| Stephen Mitchener | SVP, Chief Business Officer | 1 marca 2023 S | 128 313 | 0 | 0 | $0 |
| Sharon Shacham | Chief Scientific Officer | 29 marca 2022 A | 958 131 | 0 | 0 | $0 |
| Ran Frenkel | EVP, Chief Dev. Officer | 28 lutego 2022 A | 168 290 | 0 | 0 | $0 |
| Jatin Shah | EVP, Chief Medical Officer | 17 lutego 2022 S | 129 450 | 0 | 0 | $0 |
| John Demaree | Chief Commercial Officer | 25 lutego 2021 A | 23 995 | 0 | 0 | $0 |
| Tanya Lewis | EVP, Chief Reg. Affairs | 25 lutego 2021 A | 45 401 | 0 | 0 | $0 |
| Christopher Brett Primiano | EVP, CBO, GC & Secretary | 1 grudnia 2020 M | 4 523 | 0 | 0 | $0 |
| Cameron Peters | VP of Finance | 15 lutego 2019 A | — | 0 | 0 | $0 |
| Anand Varadan | EVP, Chief Commercial Officer | 15 lutego 2019 A | — | 0 | 0 | $0 |
| Paul Brannelly | SVP, FINANCE & ADMIN, TREAS | 15 maja 2014 P | 66 136 | 0 | 0 | $0 |
| Zhen Su | Dyrektor | 28 maja 2025 A | — | 0 | 0 | $0 |
| Christy J. Oliger | Dyrektor | 28 maja 2025 A | — | 0 | 0 | $0 |
| Mansoor Raza Mirza | Dyrektor | 28 maja 2025 A | 0 | 0 | 0 | $0 |
| Peter Honig | Dyrektor | 24 maja 2023 A | — | 0 | 0 | $0 |
| Michael Kauffman | Dyrektor | 28 lutego 2022 A | 898 131 | 0 | 0 | $0 |
| Mikael Dolsten | Dyrektor | 21 maja 2021 A | — | 0 | 0 | $0 |
| Scott J. Garland | Dyrektor | 6 czerwca 2019 A | — | 0 | 0 | $0 |
| Carsten Thiel | Dyrektor | 31 sierpnia 2018 A | — | 0 | 0 | $0 |
| Kenneth E Weg | Dyrektor | 15 czerwca 2017 A | 5 000 | 0 | 0 | $0 |
| Chen Schor | — | 21 maja 2026 A | 15 508 | 0 | 0 | $0 |
| Barry E Greene | — | 21 maja 2026 A | 16 415 | 0 | 0 | $0 |
| Deepika Pakianathan | — | 21 maja 2026 A | 15 508 | 0 | 0 | $0 |
| Garen G Bohlin | — | 21 maja 2026 A | 18 517 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| James J. Bochnowski (“Bochnowski”), David L. Douglass (“Douglass”), Deepika R. Pakianathan (“Pakianathan”), Douglas A. Roeder (“Roeder”) ×3 zgłoszenia | 7 czerwca 2017 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 13 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 lipca 2026 | Dziennie |
| IWN · iShares Trust | — | — | 17 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | — | — | 18 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 lipca 2026 | Dziennie |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 lipca 2026 | Dziennie |
| QQQS · Invesco Exchange-Traded Fund Trust … | — | — | 20 lipca 2026 | Dziennie |